(Q86088659)
Statements
A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate (English)
M Galeazzi
L Bazzichi
G D Sebastiani
D Neri
E Garcia
N Ravenni
L Giovannoni
J Wilton
M Bardelli
C Baldi
E Selvi
A Iuliano
G Minisola
R Caporali
E Prisco